Cannabis Consulting Inc

GlyTR Therapeutics is an early-stage biotech company based in Irvine, CA, focused on developing a novel class of immunotherapeutic anticancer molecules and cells that are antibody-independent. Their platform technology aims to generate bispecific proteins and chimeric antigen receptor T cells, effectively targeting cancer antigens that are abnormally expressed across various types of cancer. By addressing the limitations of current antibody-based immunotherapies, GlyTR's innovative approach seeks to induce the killing of multiple solid and blood cancers, ranging from breast cancer to leukemia. The company is dedicated to transforming cancer treatment and is eager to collaborate with leaders in cancer care research. Generated from the website

Allergan is a global specialty pharmaceutical company that develops and commercializes innovative products for the eye care, neuromodulator, skin care and other specialty markets. The company offers Alphagan, Alphagan P, Lumigan, and Restasis products for the treatment of glaucoma, and Acular, Elestat, and Alocril for the temporary relief of itch and for postoperative inflammation. It also offers Acular PF for the reduction of ocular pain and photophobia. It provides Acular LS for the reduction of ocular pain, burning and stinging, Ocuflox, an anti-infective ophthalmic solutions, and Zymar for bacterial conjunctivitis. Allergan s neuromodulator products include Botox that is used for neuromuscular disorders. The firm s skin care products include Tazorac gel for plaque psoriasis and acne, Avage for facial fine wrinkling, Azelex for mild to moderate inflammatory acne vulgaris, M.D. Forte, a glycolic acid-based skin care products, and Finacea for the treatment of rosacea. David E. I. Pyott has been the chief executive officer of Allergan for more than eight years. He has been with the drugs and bio-tech company for over eight years. Pyott earned a BS degree from the University of Edinburgh, and a MS degree from London University College. Allergan has global marketing and sales capabilities in more than 100 countries, and is located in Irvine, Calif.

Micro Therapeutics, based in Irvine, Calif., develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of endovascular diseases, including peripheral vascular, cardiovascular and neurovascular disorders. Its medical instruments are used to diagnose and treat vascular diseases and neurovascular brain disorders, including stroke. The company s catheters, infusion wires, and other products are used to dissolve blood clots in arteries, veins and hemodialysis access grafts. Its neurovascular products include infusion microcatheters and a liquid polymer embolic system used to treat aneurysms. Micro Therapeutics' offers more than 40 products in the United States and foreign markets, which are marketed by its parent company, ev3.